🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today I will be presenting at #mds2022 our work on synaptic density loss in parkinsonism. Come check it out, poster #210 today 1.30-2pm. Antonio Strafella #msca #synpark

Hospital-treated infections in early- & mid-life VS risk of #Alzheimers & #Parkinsons: A nationwide nested case-control study from Sweden finds "Hospital-treated infections, especially in early- & mid-life, were associated with an⬆️risk of AD & PD" journals.plos.org/plosmedicine/a…

#ImmunologyNCI2022 ⭐️Great #review by Jennifer Wargo MD and colleagues on how the gut #microbiota can impact immune cell function and how its modulation has therapeutic potential. Cancer Immunology Research #CIRReviewerStar⭐️ #CancerImmunology #Immunology (image from Fig. 1) aacrjournals.org/cancerimmunolr…

Motor systems should be intact in any apraxia."Apraxia of Lid Opening" (ALO), was described by Cogan in 1965 & the name stuck but all 4 of his pts & all 6 of mine in 1985 had extrapyramidal motor disorders. I think ALO is an involuntary levator inhibition & not a true apraxia.

The discovery of IgLON5 promises the uncovering of a (treatable) subtype of antibody-mediated neurodegeneration. The higher rate of false positives in autoimmune panels, however, is a challenge to overcome. One of the best talks at the #MDSCongress ⁦MDS⁩

The definitive guide to current research on the neuroprotective effects of glucagon-like peptide 1 (GLP-1) in #Alzheimers & #Parkinsons; "Novel dual agonists have been developed to cross the BBB at an enhanced rate, showing superior effects" frontiersin.org/articles/10.33…

Alberto J Espay has just killed the “vascular parkinsonism” concept. So, Alberto, should we say that is the WES era for high level gait disorders?

Parkinson's folks remember the name: LRRK2 PROTAC Degraders: First potent and selective LRRK2 proteol-ysis drug targeting chimera (PROTAC); drug name/# XL01126. Previous attempts limitated since LRRK2 inhibited protein interfered with natural mechanisms. …mentdisorders.onlinelibrary.wiley.com/doi/epdf/10.10…

LBDA is partnering with the University of Miami and Cognition Therapeutics on a new clinical trial in dementia with Lewy bodies. The SHIMMER Study was funded by a $27 million grant from the National Institute on Aging at the National Institutes of Health. ow.ly/l8io50L3toI

Researchers present lentiviral-based NLRP3 knockdown in a MPTP model of #Parkinsons (in vitro & vivo); Inhibition of the inflammasome in the substantia nigra significantly reduces dopamine neuronal loss & microglia activation onlinelibrary.wiley.com/doi/10.1002/br…

pubmed.ncbi.nlm.nih.gov/33150996/ #Parkinson

pubmed.ncbi.nlm.nih.gov/33323728/ #parkinson

prd-journal.com/article/S1353-…

Biometric "cardio cards" measure your heart rate via finger print! #aha22 #science #SciComm #AcademicTwitter #CardioTwitter #Cardiology #ECG #MedEd2022 #MedTwitter

youtu.be/Iw7dhluU1Sk Envío el link de la canción "Ven corazón mío",para presentarla a Viña 2023 ,genero folclor,Si te gusta ,dale like,y compartes👍🏽,gracias.

Honored to host this GP2 Aligning Science Across Parkinson’s LARGE-PD event at #cetram Cetram. Special acknowledgment to Pedro Chana Philippe Salles Nacho Mata & Christine Klein. Hope 2023 we could have Andrew and Artur Schumacher-Schuh 😏 in 🇨🇱

Reportaje "Dr en casa" a fundacion Distonía felicitaciones youtu.be/wRcMa2iqnOc

Molecular mechanisms of exercise contributing to tissue regeneration. Source: nature #neuroscience #MedTwitter

Todo mi apoyo a los funcionarios de INGER que se manifiestan hoy. Las personas mayores merecen horarios y atención de calidad, acordes con sus necesidades.